Webcast: STRIDE ll Consensus Statement: How to Implement in Clinical Practice

clock October 27 2026
eye 1 Min Read

The STRIDE II guidelines and treat-to-target approach are transforming the management of inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease. In this educational webinar, Jessica Figueroa from Midwest Digestive Health and Nutrition explores how healthcare professionals can apply the STRIDE II guidelines in clinical practice to improve treatment outcomes and achieve long-term disease remission. Through an engaging ulcerative colitis case study, Jessica highlights the importance of moving beyond symptom control to incorporate objective measures of inflammation, including fecal calprotectin, C-reactive protein (CRP), and endoscopic healing. Learn how to establish short-term, intermediate, and long-term treatment targets, monitor patient response to advanced IBD therapies, and determine appropriate follow-up intervals based on clinical symptoms and inflammatory biomarkers. The discussion also examines factors associated with ulcerative colitis disease progression, the importance of medication adherence, and strategies for achieving sustained clinical and endoscopic remission. This session provides valuable insights for gastroenterology healthcare professionals and advanced practice providers (APPs) looking to implement treat-to-target strategies in IBD, optimize ulcerative colitis treatment, and improve long-term patient outcomes through evidence-based disease monitoring and personalized care.

Resources

resources

Categories

  • list Video
  • list Podcast
  • list FAQ